ARCHIVES

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | March 14, 2008

Download PDF Visit The Full Archive

Related Articles

Risk Assessment Key In Long-Term Treatment

August 29, 2008

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

Amgen Website Invites Testimonials, Posts Off-Label Claims By Patients.

November 9, 2007

Wider Use Of Adjuvant Chemotherapy Recommended By NIH Consensus Panel.

November 10, 2000

Roche Reports New Avastin Results As FDA Mulls Breast Cancer Indication.

February 15, 2008

Unique Molecular Profile For Lung Cancer Described

March 31, 2006